Published in Hypertension on August 29, 2011
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis (2014) 0.95
Overview of the genetic determinants of primary aldosteronism. Appl Clin Genet (2014) 0.88
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. Sci Rep (2015) 0.86
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol Cell Endocrinol (2014) 0.83
Primary aldosteronism in 2011: Towards a better understanding of causation and consequences. Nat Rev Endocrinol (2011) 0.82
Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. Int J Mol Sci (2016) 0.80
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions. J Hum Hypertens (2015) 0.80
A differential diagnosis of inherited endocrine tumors and their tumor counterparts. Clinics (Sao Paulo) (2013) 0.77
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion. Clin Endocrinol (Oxf) (2016) 0.77
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? Int J Mol Sci (2017) 0.75
A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism. J Hum Hypertens (2013) 0.75
Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management. J Clin Endocrinol Metab (2013) 0.75
ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). J Hum Hypertens (2017) 0.75
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab (2004) 2.56
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Enhanced baroreceptor control of the cardiovascular system by polyunsaturated Fatty acids in heart failure patients. J Am Coll Cardiol (2006) 2.09
Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab (2006) 1.81
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension (2013) 1.76
Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab (2007) 1.71
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care (2013) 1.55
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens (2003) 1.52
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51
Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J Hypertens (2011) 1.50
Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up. Clin Chem (2002) 1.48
Assessment of cardiac autonomic modulation during adolescent obesity. Obes Res (2003) 1.45
Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update. Intern Emerg Med (2010) 1.43
[Assessment of cardiovascular risk in hypertensive patients: comparison among scores]. Ital Heart J Suppl (2004) 1.40
[Hypertensive emergency and urgency: clinical update]. G Ital Cardiol (Rome) (2010) 1.40
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab (2005) 1.36
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension (2002) 1.23
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab (2005) 1.19
Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens (2008) 1.17
Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. J Am Soc Echocardiogr (2010) 1.15
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab (2013) 1.15
Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab (2008) 1.12
Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci (2002) 1.07
Essential role of the p110beta subunit of phosphoinositide 3-OH kinase in male fertility. Mol Biol Cell (2010) 1.07
Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets (2007) 1.07
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension (2010) 1.05
Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med (2008) 1.05
Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens (2006) 1.05
Hypertension and cerebrovascular damage. Atherosclerosis (2008) 1.03
Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1. J Clin Endocrinol Metab (2006) 1.02
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis (2009) 1.01
Hypertension and cognitive function. Clin Exp Hypertens (2008) 0.99
Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension (2012) 0.97
Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens (2011) 0.96
Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab (2006) 0.95
Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension. Hypertens Res (2008) 0.95
Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab (2002) 0.94
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis (2008) 0.94
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension (2010) 0.94
Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens (2007) 0.94
NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α. Diabetes Care (2012) 0.94
Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol (2007) 0.94
Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem (2007) 0.93
Arterial hypertension: a cause of cognitive impairment and of vascular dementia. Clin Exp Hypertens (2004) 0.93
18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab (2012) 0.92
Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) (2007) 0.91
Aldosterone inhibition in patients with heart failure with preserved ejection fraction. JAMA (2013) 0.91
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens (2008) 0.91
Protective effect of spironolactone on endothelial cell apoptosis. Endocrinology (2006) 0.89
Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol (2012) 0.89